Published in Am J Cardiol on September 15, 1992
Drug-induced long QT syndrome. Pharmacol Rev (2010) 2.55
P wave duration and risk of longitudinal atrial fibrillation in persons ≥ 60 years old (from the Framingham Heart Study). Am J Cardiol (2011) 2.39
Sex-steroid hormones and electrocardiographic QT-interval duration: findings from the third National Health and Nutrition Examination Survey and the Multi-Ethnic Study of Atherosclerosis. Am J Epidemiol (2011) 2.38
Relation between QT and RR intervals is highly individual among healthy subjects: implications for heart rate correction of the QT interval. Heart (2002) 2.23
Drug-induced torsades de pointes and implications for drug development. J Cardiovasc Electrophysiol (2004) 2.05
PQ segment depression in patients with short QT syndrome: a novel marker for diagnosing short QT syndrome? Heart Rhythm (2014) 2.03
Prolonged QRS duration on the resting ECG is associated with sudden death risk in coronary disease, independent of prolonged ventricular repolarization. Heart Rhythm (2011) 1.69
Prolongation of QTc and risk of stroke: The REGARDS (REasons for Geographic and Racial Differences in Stroke) study. J Am Coll Cardiol (2012) 1.60
Association of early repolarization pattern on ECG with risk of cardiac and all-cause mortality: a population-based prospective cohort study (MONICA/KORA). PLoS Med (2010) 1.56
The QT interval is associated with incident cardiovascular events: the MESA study. J Am Coll Cardiol (2014) 1.53
Optimal QT interval correction formula in sinus tachycardia for identifying cardiovascular and mortality risk: Findings from the Penn Atrial Fibrillation Free study. Heart Rhythm (2015) 1.41
Pharmacokinetic-pharmacodynamic modeling in the data analysis and interpretation of drug-induced QT/QTc prolongation. AAPS J (2005) 1.37
Pharmacokinetics, safety, and cardiovascular tolerability of phenylephrine HCl 10, 20, and 30 mg after a single oral administration in healthy volunteers. Clin Drug Investig (2015) 1.36
Modulators of normal electrocardiographic intervals identified in a large electronic medical record. Heart Rhythm (2010) 1.35
Update on the evaluation of a new drug for effects on cardiac repolarization in humans: issues in early drug development. Br J Pharmacol (2009) 1.25
Overview and management of cardiac adverse events associated with tyrosine kinase inhibitors. Oncologist (2013) 1.19
QTc: how long is too long? Br J Sports Med (2009) 1.14
P-wave indices, distribution and quality control assessment (from the Framingham Heart Study). Ann Noninvasive Electrocardiol (2010) 1.12
QT interval and long-term mortality risk in the Framingham Heart Study. Ann Noninvasive Electrocardiol (2012) 1.04
Usefulness of electrocardiographic QT interval to predict left ventricular diastolic dysfunction. Am J Cardiol (2011) 1.02
More light on QT interval measurement. Heart (2002) 1.00
Comparison of formulae for heart rate correction of QT interval in exercise ECGs from healthy children. Heart (2001) 0.97
Sex differences in cardiac autonomic regulation and in repolarisation electrocardiography. Pflugers Arch (2013) 0.94
Congenital long-QT syndromes: a clinical and genetic update from infancy through adulthood. Trends Cardiovasc Med (2008) 0.92
Does artesunate prolong the electrocardiograph QT interval in patients with severe malaria? Am J Trop Med Hyg (2009) 0.92
Torsade de pointes associated with moxifloxacin: a rare but potentially fatal adverse event. Can J Cardiol (2007) 0.91
Major and minor electrocardiographic abnormalities and their association with underlying cardiovascular disease and risk factors in Hispanics/Latinos (from the Hispanic Community Health Study/Study of Latinos). Am J Cardiol (2013) 0.90
P-wave indices: derivation of reference values from the Framingham Heart Study. Ann Noninvasive Electrocardiol (2010) 0.86
Ventricular arrhythmia risk after subarachnoid hemorrhage. Neurocrit Care (2009) 0.86
Lack of correlation between exercise and sibenadet-induced changes in heart rate corrected measurement of the QT interval. Br J Clin Pharmacol (2006) 0.83
Effects of beta-adrenergic antagonists on the QT measurements from exercise stress tests in pediatric patients with long QT syndrome. Pediatr Cardiol (2003) 0.82
Normal standards for computer-ECG programs for prognostically and diagnostically important ECG variables derived from a large ethnically diverse female cohort: the Women's Health Initiative (WHI). J Electrocardiol (2013) 0.81
Which QT Correction Formulae to Use for QT Monitoring? J Am Heart Assoc (2016) 0.80
QTc interval prolongation with vascular endothelial growth factor receptor tyrosine kinase inhibitors. Br J Cancer (2014) 0.80
Impact of Age and Sex on QT Prolongation in Patients Receiving Psychotropics. Can J Psychiatry (2015) 0.80
A common variant in SLC8A1 is associated with the duration of the electrocardiographic QT interval. Am J Hum Genet (2012) 0.80
Nomenclature, categorization and usage of formulae to adjust QT interval for heart rate. World J Cardiol (2015) 0.80
Comparison of formulas for calculation of the corrected QT interval in infants and young children. J Pediatr (2015) 0.80
Disease-associated QT-shortage versus quinine associated QT-prolongation: age dependent ECG-effects in Ghanaian children with severe malaria. Malar J (2014) 0.79
Use of selective serotonin re-uptake inhibitors and the heart rate corrected QT interval in a real-life setting: the population-based Rotterdam Study. Br J Clin Pharmacol (2015) 0.79
Prolonged QT dispersion in inflammatory bowel disease. World J Gastroenterol (2013) 0.78
The phenomenon of "QT stunning": the abnormal QT prolongation provoked by standing persists even as the heart rate returns to normal in patients with long QT syndrome. Heart Rhythm (2012) 0.78
Heart rate recovery after exercise is associated with resting QTc interval in young men. Clin Auton Res (2007) 0.78
The allometric model in chronic myocardial infarction. Theor Biol Med Model (2012) 0.78
Genotype-specific QT correction for heart rate and the risk of life-threatening cardiac events in adolescents with congenital long-QT syndrome. Heart Rhythm (2011) 0.78
Recovery of heart rate variability and ventricular repolarization indices following exercise. Ann Noninvasive Electrocardiol (2012) 0.77
Maximal Exercise-Corrected QT as a Predictor of Coronary Artery Disease: Comparison of Simpler Heart Rate Corrections. Korean Circ J (2013) 0.77
Evaluation of differences in automated QT/QTc measurements between Fukuda Denshi and Nihon Koden systems. PLoS One (2014) 0.77
The fallacies of QT correction. Indian Pacing Electrophysiol J (2003) 0.76
QTc interval, and autonomic and somatic nerve function in diabetic neuropathy. Clin Auton Res (1998) 0.76
Incidence and relevance of QTc-interval prolongation caused by tyrosine kinase inhibitors. Br J Cancer (2015) 0.76
Influence of high ovarian hormones on QT interval duration in young African women. Physiol Rep (2014) 0.75
Detailed analysis of the impact of age on the QT interval. J Geriatr Cardiol (2016) 0.75
Prevalence of Brugada-type ECG pattern and early ventricular repolarization pattern in Tunisian athletes. Open Access J Sports Med (2011) 0.75
III SBC Guidelines on the Analysis and Issuance of Electrocardiographic Reports - Executive Summary. Arq Bras Cardiol (2016) 0.75
Hypokalemia in women and methadone therapy are the strongest non-cardiologic factors associated with QT prolongation in an emergency department setting. J Electrocardiol (2017) 0.75
QT interval in CKD and haemodialysis patients. Clin Kidney J (2013) 0.75
Comparison of the physiologic and prognostic implications of the heart rate versus the RR interval. Heart Rhythm (2014) 0.75
Longitudinal Community-Based Study of QT Interval and Mortality in Southeast Asians. PLoS One (2016) 0.75
A Pre-clinical Animal Model of Trypanosoma brucei Infection Demonstrating Cardiac Dysfunction. PLoS Negl Trop Dis (2015) 0.75
Aldosterone-to-Renin Ratio Is Associated With Reduced 24-Hour Heart Rate Variability and QTc Prolongation in Hypertensive Patients. Medicine (Baltimore) (2016) 0.75
Lung function, percent emphysema, and QT duration: The Multi-Ethnic Study of Atherosclerosis (MESA) lung study. Respir Med (2016) 0.75
A recommended practical approach to the management of target therapy and angiogenesis inhibitors cardiotoxicity: an opinion paper of the working group on drug cardiotoxicity and cardioprotection, Italian Society of Cardiology. J Cardiovasc Med (Hagerstown) (2016) 0.75
Adjusting the QT interval for heart rate. Am J Cardiol (1993) 0.75
Importance of QT interval in clinical practice. Singapore Med J (2014) 0.75
Ranolazine for Congenital Long-QT Syndrome Type III: Experimental and Long-Term Clinical Data. Circ Arrhythm Electrophysiol (2016) 0.75
The relationship between serum ferritin levels and electrocardiogram characteristics in acutely ill patients. Exp Clin Cardiol (2009) 0.75
Electrophysiological Characteristics of Human iPSC-Derived Cardiomyocytes for the Assessment of Drug-Induced Proarrhythmic Potential. PLoS One (2016) 0.75
Individual identification via electrocardiogram analysis. Biomed Eng Online (2015) 0.75
Intraoperative management of critical arrhythmia. Korean J Anesthesiol (2017) 0.75
Single nucleotide deletion mutation of KCNH2 gene is responsible for LQT syndrome in a 3-generation Korean family. J Korean Med Sci (2013) 0.75
QT is longer in drug-free patients with schizophrenia compared with age-matched healthy subjects. PLoS One (2014) 0.75
Racial Differences in Electrocardiographic Characteristics and Prognostic Significance in Whites Versus Asians. J Am Heart Assoc (2016) 0.75
The effects of sotalol on ventricular repolarization during exercise. J Zhejiang Univ Sci B (2005) 0.75
Tpeak-to-Tend interval corrected for heart rate: A more precise measure of increased sudden death risk? Heart Rhythm (2016) 0.75
The association between acute mental stress and abnormal left atrial electrophysiology. J Cardiovasc Electrophysiol (2017) 0.75
The ways and means of correcting the QT interval. Pediatr Cardiol (1997) 0.75
Reproducibility and Reliability Of QTc and QTcd Measurements and Their Relationships with Left Ventricular Hypertrophy in Hemodialysis Patients. Arq Bras Cardiol (2017) 0.75
Effect of selection of QTc formula on eligibility of cancer patients for phase I clinical trials. Invest New Drugs (2012) 0.75
Maintenance therapy with all-trans retinoic acid and arsenic trioxide improves relapse-free survival in adults with low- to intermediate-risk acute promyelocytic leukemia who have achieved complete remission after consolidation therapy. Onco Targets Ther (2017) 0.75
Prediction of coronary heart disease using risk factor categories. Circulation (1998) 48.81
Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation (1998) 19.93
Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA (1994) 11.63
Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med (2001) 10.54
Survival after the onset of congestive heart failure in Framingham Heart Study subjects. Circulation (1993) 9.24
Evidence for a gene influencing blood pressure on chromosome 17. Genome scan linkage results for longitudinal blood pressure phenotypes in subjects from the framingham heart study. Hypertension (2000) 8.84
The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol (1993) 8.01
A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med (1991) 7.62
The progression from hypertension to congestive heart failure. JAMA (1996) 7.56
Lifetime risk of developing coronary heart disease. Lancet (1999) 7.54
Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation (1997) 7.34
Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates. Am J Cardiol (1998) 6.76
Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med (1999) 6.72
Triggering of acute myocardial infarction by heavy physical exertion. Protection against triggering by regular exertion. Determinants of Myocardial Infarction Onset Study Investigators. N Engl J Med (1993) 6.72
Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study. Circulation (1996) 6.20
Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA (2000) 6.00
Accuracy of death certificates for coding coronary heart disease as the cause of death. Ann Intern Med (1998) 5.63
Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet (2001) 5.54
Congestive heart failure in subjects with normal versus reduced left ventricular ejection fraction: prevalence and mortality in a population-based cohort. J Am Coll Cardiol (1999) 5.43
Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart Study. Circulation (2001) 5.11
Sex differences in 2-year mortality after hospital discharge for myocardial infarction. Ann Intern Med (2001) 5.05
Is pulse pressure useful in predicting risk for coronary heart Disease? The Framingham heart study. Circulation (1999) 5.04
Prevalence and clinical outcome of mitral-valve prolapse. N Engl J Med (1999) 5.01
Defining diastolic heart failure: a call for standardized diagnostic criteria. Circulation (2000) 4.63
Interferon-induced transcription of a gene encoding a 15-kDa protein depends on an upstream enhancer element. Proc Natl Acad Sci U S A (1987) 4.61
Comparisons of five health status instruments for orthopedic evaluation. Med Care (1990) 4.57
Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study. Circulation (1994) 4.52
Increased left ventricular mass and hypertrophy are associated with increased risk for sudden death. J Am Coll Cardiol (1998) 4.44
The somatic replication of DNA methylation. Cell (1981) 4.42
Recent changes in attack and survival rates of acute myocardial infarction (1975 through 1981). The Worcester Heart Attack Study. JAMA (1986) 4.20
Risk factors for incident radiographic knee osteoarthritis in the elderly: the Framingham Study. Arthritis Rheum (1997) 4.08
Cholesterol and mortality. 30 years of follow-up from the Framingham study. JAMA (1987) 4.05
Left atrial size and the risk of stroke and death. The Framingham Heart Study. Circulation (1995) 4.04
Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum (1989) 4.02
The carpal tunnel syndrome: diagnostic utility of the history and physical examination findings. Ann Intern Med (1990) 4.02
Bone mass and the risk of breast cancer among postmenopausal women. N Engl J Med (1997) 3.96
The incidence and natural history of knee osteoarthritis in the elderly. The Framingham Osteoarthritis Study. Arthritis Rheum (1995) 3.93
Evidence for association and genetic linkage of the angiotensin-converting enzyme locus with hypertension and blood pressure in men but not women in the Framingham Heart Study. Circulation (1998) 3.89
Cancer: improving early detection and prevention. A community practice randomised trial. BMJ (1992) 3.76
Prognostic value of a treadmill exercise score in outpatients with suspected coronary artery disease. N Engl J Med (1991) 3.63
Effects of ambient air pollution on nonelderly asthma hospital admissions in Seattle, Washington, 1987-1994. Epidemiology (1999) 3.57
Insulin resistance, oxidative stress, hypertension, and leukocyte telomere length in men from the Framingham Heart Study. Aging Cell (2006) 3.44
Reduced heart rate variability and mortality risk in an elderly cohort. The Framingham Heart Study. Circulation (1994) 3.44
A controlled trial of an educational program to prevent low back injuries. N Engl J Med (1997) 3.33
The long-term clinical outcomes of Lyme disease. A population-based retrospective cohort study. Ann Intern Med (1994) 3.20
Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective. J Am Coll Cardiol (1995) 3.19
Patient-specific decisions about hormone replacement therapy in postmenopausal women. JAMA (1997) 3.18
Seasonal distribution of acute myocardial infarction in the second National Registry of Myocardial Infarction. J Am Coll Cardiol (1998) 3.16
Prognosis of left ventricular geometric patterns in the Framingham Heart Study. J Am Coll Cardiol (1995) 3.08
Impaired heart rate response to graded exercise. Prognostic implications of chronotropic incompetence in the Framingham Heart Study. Circulation (1996) 3.07
Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int (1999) 2.95
Interferon-stimulated transcription: isolation of an inducible gene and identification of its regulatory region. Proc Natl Acad Sci U S A (1986) 2.92
Comparative measurement sensitivity of short and longer health status instruments. Med Care (1992) 2.89
Reduced heart rate variability and new-onset hypertension: insights into pathogenesis of hypertension: the Framingham Heart Study. Hypertension (1998) 2.86
Comparative measurement efficiency and sensitivity of five health status instruments for arthritis research. Arthritis Rheum (1985) 2.85
Profile for estimating risk of heart failure. Arch Intern Med (1999) 2.81
Left ventricular dilatation and the risk of congestive heart failure in people without myocardial infarction. N Engl J Med (1997) 2.81
Mitral annular calcification and the risk of stroke in an elderly cohort. N Engl J Med (1992) 2.77
Clinical Advisory Statement. Importance of systolic blood pressure in older Americans. Hypertension (2000) 2.76
Type C particle-positive and type C particle-negative rat cell lines: characterization of the coding capacity of endogenous sarcoma virus-specific RNA. J Virol (1976) 2.67
A residents' training program for the development of smoking intervention skills. Arch Intern Med (1988) 2.61
Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study. Am J Cardiol (1987) 2.60
ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stable Angina). J Am Coll Cardiol (1999) 2.58
Total serum bilirubin and risk of cardiovascular disease in the Framingham offspring study. Am J Cardiol (2001) 2.57
Genetic and environmental contributions to platelet aggregation: the Framingham heart study. Circulation (2001) 2.54
Trends in the prevalence of hypertension, antihypertensive therapy, and left ventricular hypertrophy from 1950 to 1989. N Engl J Med (1999) 2.53
Clinical recommendations using levels of evidence for antithrombotic agents. Chest (1995) 2.52
Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study) Am J Cardiol (1999) 2.51
Absence of association or genetic linkage between the angiotensin-converting-enzyme gene and left ventricular mass. N Engl J Med (1996) 2.49
Secular trends in the prevalence of atrial fibrillation: The Framingham Study. Am Heart J (1996) 2.47
Reconstitution of membrane proteins into liposomes: application to energy-transducing membrane proteins. Biochim Biophys Acta (1995) 2.47
Evidence for a Mendelian gene in a segregation analysis of generalized radiographic osteoarthritis: the Framingham Study. Arthritis Rheum (1998) 2.45
The impact of obesity on left ventricular mass and geometry. The Framingham Heart Study. JAMA (1991) 2.44
Association of hyperglycemia with reduced heart rate variability (The Framingham Heart Study). Am J Cardiol (2000) 2.28
Prognosis after the onset of coronary heart disease. An investigation of differences in outcome between the sexes according to initial coronary disease presentation. Circulation (1993) 2.27